Background illustration for clinical trials search

Paid Clinical Trials Brockton

Discover 3,059 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Myo-inositol During Pregnancy to Prevent Gestational Diabetes

for
Pregnancy Related
Location: Boston MA
Sponsor: Tufts Medical Center

Sex: Female

Age: 18 - 45

Code: NCT06575868

Recruiting

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Boston MA, Providence RI, Hartford CT, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT04684368

Phase 2, Recruiting

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

for
Congenital Disorders of Glycosylation
Location: Boston MA, New York NY, Philadelphia PA, Pittsburgh PA,
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 0+

Code: NCT04199000

Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

for
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Location: Boston MA, Providence RI, Worcester MA, Westerly RI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 5 - 60

Code: NCT05675410

Phase 3, Recruiting

A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)

for
New Onset Generalized Myasthenia Gravis (gMG)
Location: Worcester MA, Cleveland OH, Detroit MI, Greenfield WI,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT06909214

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

for
Solid Tumor, Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Boston MA, New Haven CT, New York NY, Hickory NC,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06952010

Phase 1, Recruiting

ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

for
Advanced Solid Tumor, PDAC, HNSCC
Location: Boston MA, New Haven CT, New York NY, St Louis MO,
Sponsor: Adcendo ApS

Sex: All

Age: 18+

Code: NCT06597721

Phase 1, Recruiting

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

for
Sickle Cell Disease
Location: Boston MA, Providence RI, New York NY, Philadelphia PA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 55

Code: NCT06546670

Phase 1, Phase 2, Recruiting

Neuroblastoma Biology Study

for
Neuroblastoma
Location: Boston MA, Philadelphia PA, Toronto, Columbus OH,
Sponsor: New Approaches to Neuroblastoma Therapy Consortium

Sex: All

Age: 0 - 70+

Code: NCT01587300

Recruiting

Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma

for
Relapsed Neuroblastoma, Refractory Neuroblastoma,
Location: Boston MA
Sponsor: Roberto Chiarle

Sex: All

Age: 1 - 29

Code: NCT06803875

Phase 1, Phase 2, Recruiting

Longitudinal Study of Urea Cycle Disorders

for
Brain Diseases, Metabolic, Inborn,
Location: Boston MA, New York NY, Philadelphia PA, Washington DC,
Sponsor: Andrea Gropman

Sex: All

Age: 0+

Code: NCT00237315

Recruiting

52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism

for
Hypogonadism, Male
Location: Boston MA, Worcester MA, The Bronx NY, Philadelphia PA,
Sponsor: Halozyme Therapeutics

Sex: Male

Age: 12 - 17

Code: NCT06689085

Phase 3, Recruiting

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

for
Gaucher Disease, Cerebroside Lipidosis Syndrome,
Location: Boston MA, New Haven CT, Portland ME, Huntington NY,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00358943

Recruiting

Blood Pressure Variability and Ischemic Stroke Outcome

for
Acute Ischemic Stroke, Blood Pressure Variability
Location: Boston MA, New Haven CT, Chicago IL
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT05756257

Recruiting

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

for
Advanced HR+/HER2- Breast Cancer,
Location: Boston MA, New York NY, Montreal, Toronto, Nashville TN,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06726148

Phase 1, Phase 2, Recruiting

Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer

for
Colorectal Neoplasms
Location: Worcester MA, Philadelphia PA, Weston FL, Duarte CA,
Sponsor: Surgimab

Sex: All

Age: 18+

Code: NCT03659448

Phase 3, Recruiting

Amnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers

for
Venous Leg Ulcers
Location: Boston MA, Brick NJ, Ford City PA, Kittanning PA,
Sponsor: SerenaGroup, Inc.

Sex: All

Age: 18+

Code: NCT02609594

Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Boston MA, North Worcester MA, New Haven CT, Albany NY,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase 2, Phase 3, Recruiting

Comparison of the Q-NRG+ Indirect Calorimetry Device Versus the V(Max) Encore Device in Mechanically Ventilated Children

for
Calorimetry, Indirect, Oxygen Consumption, Metabolism,
Location: Boston MA
Sponsor: Boston Children's Hospital

Sex: All

Age: 10 - 18

Code: NCT04482556

Recruiting

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Boston MA, Providence RI, Hartford CT, Scarborough ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 30

Code: NCT06172296

Phase 3, Recruiting